Sequential Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$6.21M
- Investors
-
14
Sequential General Information
Description
Developer of a microbiome testing and formulation platform designed to advance consumer skin microbiome analysis and research. The company's platform supports clinical study design, participant recruitment, non-invasive sampling, sequencing, and qPCR analysis, biomarker discovery, data interpretation, and in vivo microbiome certification, enabling the personal care, beauty, and pharmaceutical brands to generate science-backed claims and differentiate products.
Contact Information
Website
www.sequential.bioCorporate Office
- 85 Great Portland Street
- London W1W 7LT
- England, United Kingdom
Corporate Office
- 85 Great Portland Street
- London W1W 7LT
- England, United Kingdom
Sequential Timeline
Sequential Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Seed Round | 17-Mar-2026 | $6.21M | Completed | Profitable | ||
| 9. Seed Round | 01-Sep-2024 | Completed | Profitable | |||
| 8. Accelerator/Incubator | 01-May-2024 | Completed | Profitable | |||
| 7. Accelerator/Incubator | 01-Feb-2024 | Completed | Profitable | |||
| 6. Seed Round | 10-Sep-2022 | Completed | Profitable | |||
| 5. Grant | 29-Jun-2022 | Completed | Profitable | |||
| 4. Seed Round | 11-Oct-2021 | Completed | Profitable | |||
| 3. Accelerator/Incubator | 01-Oct-2021 | Completed | Profitable | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | $500K | $500K | Completed | Profitable | |
| 1. Grant | 01-Oct-2019 | $72.5K | Completed | Profitable |
Sequential Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series Seed 5 | ||||||||
| Series Seed 4 | ||||||||
| Series Seed 3 | ||||||||
| Series Seed 2 | ||||||||
| Series Seed 1 | 24,441 | $0.001343 | $144.81 | $144.81 | 1x | $144.81 | 14.82% | |
| Ordinary | 1,057 | $0.001343 | $95.33 | $95.33 | 1x | $95.33 | 0.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sequential Signals
Sequential Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dermazone Holdings | Corporation | Minority | ||
| Sparkfood | Corporate Venture Capital | Minority | ||
| Grow London | Accelerator/Incubator | |||
| Corundum Systems Biology | Venture Capital | Minority | ||
| Innovate UK | Government |
Sequential FAQs
-
When was Sequential founded?
Sequential was founded in 2019.
-
Where is Sequential headquartered?
Sequential is headquartered in London, United Kingdom.
-
What is the size of Sequential?
Sequential has 18 total employees.
-
What industry is Sequential in?
Sequential’s primary industry is Laboratory Services (Healthcare).
-
Is Sequential a private or public company?
Sequential is a Private company.
-
What is the current valuation of Sequential?
The current valuation of Sequential is .
-
What is Sequential’s current revenue?
The current revenue for Sequential is .
-
How much funding has Sequential raised over time?
Sequential has raised $10M.
-
Who are Sequential’s investors?
Dermazone Holdings, Sparkfood, Grow London, Corundum Systems Biology, and Innovate UK are 5 of 14 investors who have invested in Sequential.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process